Cargando…

Offset of apparent hyperpolarized (13)C lactate flux by the use of adjuvant metformin in ionizing radiation therapy in vivo

An increase in hyperpolarized (HP) [1‐(13)C]lactate production has been suggested as a biomarker for cancer occurrence as well as for response monitoring of cancer treatment. Recently, the use of metformin has been suggested as an anticancer or adjuvant treatment. By regulating the cytosolic NAD(+)/...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Young‐Suk, Lee, Joonsung, Lee, Han‐Sol, Song, Jae Eun, Kim, Dong‐Hyun, Song, Ho‐Taek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365667/
https://www.ncbi.nlm.nih.gov/pubmed/34080736
http://dx.doi.org/10.1002/nbm.4561
_version_ 1783738753701904384
author Choi, Young‐Suk
Lee, Joonsung
Lee, Han‐Sol
Song, Jae Eun
Kim, Dong‐Hyun
Song, Ho‐Taek
author_facet Choi, Young‐Suk
Lee, Joonsung
Lee, Han‐Sol
Song, Jae Eun
Kim, Dong‐Hyun
Song, Ho‐Taek
author_sort Choi, Young‐Suk
collection PubMed
description An increase in hyperpolarized (HP) [1‐(13)C]lactate production has been suggested as a biomarker for cancer occurrence as well as for response monitoring of cancer treatment. Recently, the use of metformin has been suggested as an anticancer or adjuvant treatment. By regulating the cytosolic NAD(+)/NADH redox state, metformin stimulates lactate production and increases the HP [1‐(13)C]lactate conversion rate in the kidney, liver, and heart. In general, increased HP [1‐(13)C]lactate is regarded as a sign of cancer occurrence or tumor growth. Thus, the relationship between the tumor suppression effect of metformin and the change in metabolism monitored by HP [1‐(13)C]pyruvate MRS in cancer treatment needs to be investigated. The present study was performed using a brain metastasis animal model with MDA‐MB‐231(BR)‐Luc breast cancer cells. HP [1‐(13)C]pyruvate MRS, T (2)‐weighted MRI, and bioluminescence imaging were performed in groups treated with metformin or adjuvant metformin and radiation therapy. Metformin treatment alone did not display a tumor suppression effect, and the HP [1‐(13)C]lactate conversion rate increased. In radiation therapy, the HP [1‐(13)C]lactate conversion rate decreased with tumor suppression, with a p‐value of 0.028. In the adjuvant metformin and radiation treatment, the tumor suppression effect increased, with a p‐value of 0.001. However, the apparent HP [1‐(13)C]lactate conversion rate (K (pl)) was observed to be offset by two opposite effects: a decrease on radiation therapy and an increase caused by metformin treatment. Although HP [1‐(13)C]pyruvate MRS could not evaluate the tumor suppression effect of adjuvant metformin and radiation therapy due to the offset phenomenon, metabolic changes following only metformin pre‐treatment could be monitored. Therefore, our results indicate that the interpretation of HP [1‐(13)C]pyruvate MRS for response monitoring of cancer treatment should be carried out with caution when metformin is used as an adjuvant cancer therapy.
format Online
Article
Text
id pubmed-8365667
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-83656672021-08-23 Offset of apparent hyperpolarized (13)C lactate flux by the use of adjuvant metformin in ionizing radiation therapy in vivo Choi, Young‐Suk Lee, Joonsung Lee, Han‐Sol Song, Jae Eun Kim, Dong‐Hyun Song, Ho‐Taek NMR Biomed Research Articles An increase in hyperpolarized (HP) [1‐(13)C]lactate production has been suggested as a biomarker for cancer occurrence as well as for response monitoring of cancer treatment. Recently, the use of metformin has been suggested as an anticancer or adjuvant treatment. By regulating the cytosolic NAD(+)/NADH redox state, metformin stimulates lactate production and increases the HP [1‐(13)C]lactate conversion rate in the kidney, liver, and heart. In general, increased HP [1‐(13)C]lactate is regarded as a sign of cancer occurrence or tumor growth. Thus, the relationship between the tumor suppression effect of metformin and the change in metabolism monitored by HP [1‐(13)C]pyruvate MRS in cancer treatment needs to be investigated. The present study was performed using a brain metastasis animal model with MDA‐MB‐231(BR)‐Luc breast cancer cells. HP [1‐(13)C]pyruvate MRS, T (2)‐weighted MRI, and bioluminescence imaging were performed in groups treated with metformin or adjuvant metformin and radiation therapy. Metformin treatment alone did not display a tumor suppression effect, and the HP [1‐(13)C]lactate conversion rate increased. In radiation therapy, the HP [1‐(13)C]lactate conversion rate decreased with tumor suppression, with a p‐value of 0.028. In the adjuvant metformin and radiation treatment, the tumor suppression effect increased, with a p‐value of 0.001. However, the apparent HP [1‐(13)C]lactate conversion rate (K (pl)) was observed to be offset by two opposite effects: a decrease on radiation therapy and an increase caused by metformin treatment. Although HP [1‐(13)C]pyruvate MRS could not evaluate the tumor suppression effect of adjuvant metformin and radiation therapy due to the offset phenomenon, metabolic changes following only metformin pre‐treatment could be monitored. Therefore, our results indicate that the interpretation of HP [1‐(13)C]pyruvate MRS for response monitoring of cancer treatment should be carried out with caution when metformin is used as an adjuvant cancer therapy. John Wiley and Sons Inc. 2021-06-03 2021-08 /pmc/articles/PMC8365667/ /pubmed/34080736 http://dx.doi.org/10.1002/nbm.4561 Text en © 2021 The Authors. NMR in Biomedicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Research Articles
Choi, Young‐Suk
Lee, Joonsung
Lee, Han‐Sol
Song, Jae Eun
Kim, Dong‐Hyun
Song, Ho‐Taek
Offset of apparent hyperpolarized (13)C lactate flux by the use of adjuvant metformin in ionizing radiation therapy in vivo
title Offset of apparent hyperpolarized (13)C lactate flux by the use of adjuvant metformin in ionizing radiation therapy in vivo
title_full Offset of apparent hyperpolarized (13)C lactate flux by the use of adjuvant metformin in ionizing radiation therapy in vivo
title_fullStr Offset of apparent hyperpolarized (13)C lactate flux by the use of adjuvant metformin in ionizing radiation therapy in vivo
title_full_unstemmed Offset of apparent hyperpolarized (13)C lactate flux by the use of adjuvant metformin in ionizing radiation therapy in vivo
title_short Offset of apparent hyperpolarized (13)C lactate flux by the use of adjuvant metformin in ionizing radiation therapy in vivo
title_sort offset of apparent hyperpolarized (13)c lactate flux by the use of adjuvant metformin in ionizing radiation therapy in vivo
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365667/
https://www.ncbi.nlm.nih.gov/pubmed/34080736
http://dx.doi.org/10.1002/nbm.4561
work_keys_str_mv AT choiyoungsuk offsetofapparenthyperpolarized13clactatefluxbytheuseofadjuvantmetformininionizingradiationtherapyinvivo
AT leejoonsung offsetofapparenthyperpolarized13clactatefluxbytheuseofadjuvantmetformininionizingradiationtherapyinvivo
AT leehansol offsetofapparenthyperpolarized13clactatefluxbytheuseofadjuvantmetformininionizingradiationtherapyinvivo
AT songjaeeun offsetofapparenthyperpolarized13clactatefluxbytheuseofadjuvantmetformininionizingradiationtherapyinvivo
AT kimdonghyun offsetofapparenthyperpolarized13clactatefluxbytheuseofadjuvantmetformininionizingradiationtherapyinvivo
AT songhotaek offsetofapparenthyperpolarized13clactatefluxbytheuseofadjuvantmetformininionizingradiationtherapyinvivo